Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
cRAF inhibitor
DRUG CLASS:
cRAF inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
encorafenib (63)
VS-6766 (27)
ERAS-254 (7)
RAF709 (3)
donafenib (2)
BMS-908662 (0)
encorafenib (63)
VS-6766 (27)
ERAS-254 (7)
RAF709 (3)
donafenib (2)
BMS-908662 (0)
›
Associations
(102)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF V600E
Colorectal Cancer
BRAF V600E
Colorectal Cancer
cetuximab + binimetinib + encorafenib
Sensitive: A1 - Approval
cetuximab + binimetinib + encorafenib
Sensitive
:
A1
cetuximab + binimetinib + encorafenib
Sensitive: A1 - Approval
cetuximab + binimetinib + encorafenib
Sensitive
:
A1
BRAF V600E
Colorectal Cancer
BRAF V600E
Colorectal Cancer
cetuximab + encorafenib
Sensitive: A1 - Approval
cetuximab + encorafenib
Sensitive
:
A1
cetuximab + encorafenib
Sensitive: A1 - Approval
cetuximab + encorafenib
Sensitive
:
A1
BRAF V600
Melanoma
BRAF V600
Melanoma
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
BRAF V600K
Melanoma
BRAF V600K
Melanoma
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
BRAF V600E
Melanoma
BRAF V600E
Melanoma
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
BRAF V600E
Non Small Cell Lung Cancer
BRAF V600E
Non Small Cell Lung Cancer
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
BRAF V600
Cutaneous Melanoma
BRAF V600
Cutaneous Melanoma
binimetinib + encorafenib
Sensitive: A2 - Guideline
binimetinib + encorafenib
Sensitive
:
A2
binimetinib + encorafenib
Sensitive: A2 - Guideline
binimetinib + encorafenib
Sensitive
:
A2
BRAF V600E
Colorectal Cancer
BRAF V600E
Colorectal Cancer
panitumumab + encorafenib
Sensitive: A2 - Guideline
panitumumab + encorafenib
Sensitive
:
A2
panitumumab + encorafenib
Sensitive: A2 - Guideline
panitumumab + encorafenib
Sensitive
:
A2
BRAF V600E
Cutaneous Melanoma
BRAF V600E
Cutaneous Melanoma
binimetinib + encorafenib
Sensitive: A2 - Guideline
binimetinib + encorafenib
Sensitive
:
A2
binimetinib + encorafenib
Sensitive: A2 - Guideline
binimetinib + encorafenib
Sensitive
:
A2
BRAF V600K
Cutaneous Melanoma
BRAF V600K
Cutaneous Melanoma
binimetinib + encorafenib
Sensitive: A2 - Guideline
binimetinib + encorafenib
Sensitive
:
A2
binimetinib + encorafenib
Sensitive: A2 - Guideline
binimetinib + encorafenib
Sensitive
:
A2
BRAF V600
Rectal Cancer
BRAF V600
Rectal Cancer
cetuximab + encorafenib
Sensitive: A2 - Guideline
cetuximab + encorafenib
Sensitive
:
A2
cetuximab + encorafenib
Sensitive: A2 - Guideline
cetuximab + encorafenib
Sensitive
:
A2
BRAF V600
Rectal Cancer
BRAF V600
Rectal Cancer
panitumumab + encorafenib
Sensitive: A2 - Guideline
panitumumab + encorafenib
Sensitive
:
A2
panitumumab + encorafenib
Sensitive: A2 - Guideline
panitumumab + encorafenib
Sensitive
:
A2
BRAF V600E
Colon Cancer
BRAF V600E
Colon Cancer
panitumumab + encorafenib
Sensitive: A2 - Guideline
panitumumab + encorafenib
Sensitive
:
A2
panitumumab + encorafenib
Sensitive: A2 - Guideline
panitumumab + encorafenib
Sensitive
:
A2
BRAF V600E
Colon Cancer
BRAF V600E
Colon Cancer
cetuximab + encorafenib
Sensitive: A2 - Guideline
cetuximab + encorafenib
Sensitive
:
A2
cetuximab + encorafenib
Sensitive: A2 - Guideline
cetuximab + encorafenib
Sensitive
:
A2
BRAF V600K
Melanoma
BRAF V600K
Melanoma
encorafenib
Sensitive: B - Late Trials
encorafenib
Sensitive
:
B
encorafenib
Sensitive: B - Late Trials
encorafenib
Sensitive
:
B
BRAF V600E
Melanoma
BRAF V600E
Melanoma
encorafenib
Sensitive: B - Late Trials
encorafenib
Sensitive
:
B
encorafenib
Sensitive: B - Late Trials
encorafenib
Sensitive
:
B
BRAF V600E
Colorectal Cancer
BRAF V600E
Colorectal Cancer
encorafenib
Sensitive: B - Late Trials
encorafenib
Sensitive
:
B
encorafenib
Sensitive: B - Late Trials
encorafenib
Sensitive
:
B
BRAF V600E
Colorectal Cancer
BRAF V600E
Colorectal Cancer
binimetinib + encorafenib
Sensitive: B - Late Trials
binimetinib + encorafenib
Sensitive
:
B
binimetinib + encorafenib
Sensitive: B - Late Trials
binimetinib + encorafenib
Sensitive
:
B
KRAS wild-type
Ovarian Cancer
KRAS wild-type
Ovarian Cancer
VS-6766 + VS-6063
Sensitive: B - Late Trials
VS-6766 + VS-6063
Sensitive
:
B
VS-6766 + VS-6063
Sensitive: B - Late Trials
VS-6766 + VS-6063
Sensitive
:
B
NRAS mutation
Melanoma
NRAS mutation
Melanoma
trametinib + ERAS-254
Sensitive: B - Late Trials
trametinib + ERAS-254
Sensitive
:
B
trametinib + ERAS-254
Sensitive: B - Late Trials
trametinib + ERAS-254
Sensitive
:
B
BRAF V600E + BRAF V600K
Melanoma
BRAF V600E + BRAF V600K
Melanoma
binimetinib + encorafenib
Sensitive: B - Late Trials
binimetinib + encorafenib
Sensitive
:
B
binimetinib + encorafenib
Sensitive: B - Late Trials
binimetinib + encorafenib
Sensitive
:
B
BRAF V600
Multiple Myeloma
BRAF V600
Multiple Myeloma
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
BRAF V600E
Ovarian Serous Adenocarcinoma
BRAF V600E
Ovarian Serous Adenocarcinoma
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
BRAF V600E
Pancreatic Cancer
BRAF V600E
Pancreatic Cancer
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
BRAF V600E
Solid Tumor
BRAF V600E
Solid Tumor
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
BRAF V600K
Solid Tumor
BRAF V600K
Solid Tumor
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
BRAF V600
Non Small Cell Lung Cancer
BRAF V600
Non Small Cell Lung Cancer
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
BRAF V600E
Neuroendocrine Tumor
BRAF V600E
Neuroendocrine Tumor
cetuximab + encorafenib
Sensitive: C1 - Off-label
cetuximab + encorafenib
Sensitive
:
C1
cetuximab + encorafenib
Sensitive: C1 - Off-label
cetuximab + encorafenib
Sensitive
:
C1
BRAF V600E
Glioma
BRAF V600E
Glioma
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
BRAF V600E
Glioblastoma
BRAF V600E
Glioblastoma
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
binimetinib + encorafenib
Sensitive: C1 - Off-label
binimetinib + encorafenib
Sensitive
:
C1
BRAF V600
Melanoma
BRAF V600
Melanoma
encorafenib
Sensitive: C2 – Inclusion Criteria
encorafenib
Sensitive
:
C2
encorafenib
Sensitive: C2 – Inclusion Criteria
encorafenib
Sensitive
:
C2
BRAF mutation
Melanoma
BRAF mutation
Melanoma
binimetinib + encorafenib
Sensitive: C2 – Inclusion Criteria
binimetinib + encorafenib
Sensitive
:
C2
binimetinib + encorafenib
Sensitive: C2 – Inclusion Criteria
binimetinib + encorafenib
Sensitive
:
C2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login